Siemens Healthcare is selling its microbiology business to Beckman Coulter Inc., a wholly owned subsidiary of Danaher Corporation. The activities of the microbiology business include systems for the identification and antibiotic susceptibility testing (ID/AST) of microorganisms. The decision enables Siemens Healthcare to focus on its core in-vitro business within the Diagnostics Division and is also in alignment with Siemens – Vision 2020. It has been agreed not to disclose details of this transaction. The transaction is subject to applicable regulatory approvals.
Siemens to sell microbiology business
to Beckman Coulter, a subsidary of Danaher
- July 23, 2014
- 453 views
Siemens to sell microbiology business
Disclaimer: Content published by TIM Global Media, including text, images, and videos, is either created in-house or provided by Suppliers/Manufacturers with their approval. Suppliers/Manufactures warrant that their materials do not infringe third-party rights and agree to indemnify and hold TIM Global Media harmless from any related claims.
